FDA announces labeling changes to opioid pain medications
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain the risks associated with long-term use. The updates include presenting clearer risk information, stronger dosing warnings, clarified language on use limits, treatment guidance and more. Manufacturers were given 30 days to submit their labeling updates to the FDA for review.
Related News Articles
Headline
The Department of Health and Human Services Office for Civil Rights released new guidance on statutory and regulatory requirements under 42 CFR Part 2, which…
Headline
The Health Resources and Services Administration announced Sept. 25 that it awarded $89.3 million in grants to expand access to substance use disorder…
Headline
The Substance Abuse and Mental Health Services Administration Sept. 25 announced that it awarded $247.9 million in grants for services expanding access to…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
HHS awards $383 million in grants for suicide prevention, other behavioral health efforts on 988 Day
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…